– Second Quarter 2025 Financial Results and Corporate Update Rescheduled to Monday, August 11, 2025, at 4:30 p.m. ET –
Capricor Therapeutics Announces Type A Meeting Scheduled with U.S. FDA
Seeking Alpha / 43 minutes from now 1 Views
– Second Quarter 2025 Financial Results and Corporate Update Rescheduled to Monday, August 11, 2025, at 4:30 p.m. ET –
Comments